Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/2010
08/19/2010US20100210831 Immunocytokine Sequences and Uses Thereof
08/19/2010US20100210829 Compositions and Methods for Treating Diseases, Disorders, or Conditions Characterized by Myelin Degeneration, Myelin Deficiency or Loss
08/19/2010US20100210816 NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia
08/19/2010US20100210815 Insulin production methods and pro-insulin constructs
08/19/2010US20100210714 Her-2/neu DNA Vaccine Having Anti-Cancer Activity
08/19/2010US20100210712 Short RNA Antagonist Compounds for the Modulation of Target mRNA
08/19/2010US20100210710 THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO
08/19/2010US20100210707 Small Activating RNA Molecules and Methods of Use
08/19/2010US20100210563 Metastasis-specific peptides and their diagnostic and therapeutic applications
08/19/2010US20100210543 Aldehyde-Tagged Protein-Based Drug Carriers and Methods of Use
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210521 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210024 Methods For Producing Surface Bound Oligonucleotide on Solid Substrate and Uses Thereof
08/19/2010US20100209999 Phage ømru polynucleotides and polypeptides and uses thereof
08/19/2010US20100209997 Carbonic anhydrase polypeptides and uses thereof
08/19/2010US20100209994 Protein Surface Remodeling
08/19/2010US20100209985 Novel esterases and their use
08/19/2010US20100209977 L-amino acid-producing bacterium and a method for producing an l-amino acid
08/19/2010US20100209969 Geraniol synthase, methods of production and uses thereof
08/19/2010US20100209936 Novel recombinant 15-kDa polypeptide and use of same in detecting human infection with Bartonella henselae
08/19/2010US20100209933 Methods and Compositions for Detection and Enrichment of Target Small RNAs
08/19/2010US20100209923 Probe for diagnosis of marfan syndrome and a method for screening using the probe
08/19/2010US20100209919 Polynucleotide markers
08/19/2010US20100209917 Polymorphic length of foxe1 alanine stretch and genetic susceptibility to thyroid dysgenesis
08/19/2010US20100209911 Microsatellite maker combination and method for identifying Lanyu pig breed
08/19/2010US20100209907 Isolated mammalian monocyte cell genes; related reagents
08/19/2010US20100209906 Methods and compositions for detecting colon cancers
08/19/2010US20100209903 Method for measuring resistance of a patient HIV-2 to protease inhibitors
08/19/2010US20100209491 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209451 Compositions and Methods Related to Adenovirus Based Delivery of Antigens
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209426 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells and cells in which the beta-catenin/tcf-mediated transcriptional pathway is constitutively active
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209413 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/19/2010US20100209395 Solenopsis invicta virus
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100206730 Internal Calibration Standards for Electrophoretic Analyses
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/18/2010EP2218779A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
08/18/2010EP2218727A1 Modulation of C-reactive protein expression
08/18/2010EP2218726A1 Sorting and immobilization system for nucleic acids using synthetic binding systems
08/18/2010EP2217612A1 Preparation of nucleotide oligomer
08/18/2010EP1625219B1 Methods for producing secreted polypeptides
08/18/2010EP1261616B1 Modified oligonucleotides for mismatch discrimination
08/18/2010EP1171632B1 Nucleic acid ligand inhibitors to dna polymerases
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN101809171A In-situ hybridization to detect RNA and DNA markers
08/18/2010CN101809164A Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex
08/18/2010CN101805730A Convenient and rapid DNA extracting method of peanut health tissues and diseased tissues
08/17/2010US7777100 DNA sequences from tcd genomic region of Photorhabdus luminescens
08/17/2010US7777024 Process for preparing a pentopyranosyl nucleic acid conjugate
08/17/2010US7777023 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass
08/17/2010US7777022 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
08/17/2010US7777021 can effectively drive the expression of heterologous genes in mushroom such as Pleurotus ostreatus
08/17/2010US7777020 Nucleotide sequences derived from the env gene of HIV-1
08/17/2010US7777019 nucleic acid encoding the antibodies conjugated to radioisotope, drug, cytotoxic agent or biodrug; immunotoxin of use to treat cancer; immunoassay kit for detection of CD 22+ cancer cells; lymphoma
08/17/2010US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
08/17/2010US7777017 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo
08/17/2010US7777016 YbeJ-based glutamate binding biosensors comprising a neurotransmitter binding domain conjugated to donor and fluorescent moieties that permit detection and measurement of Fluorescence Resonance Energy Transfer upon binding; for the detection of neurotransmitter concentrations in vivo and in culture
08/17/2010US7777015 Cytochrome P-450 gene cluster from Rhodococcus ruber and uses thereof in ether fuel cleavage
08/17/2010US7777014 double-stranded decoy oligonucleotide; atherosclerosis; acts as a competitive inhibitor (or rather neutralisation) of a natural core-binding sequence of a DNA-binding protein or protein complex thereby blocks the expression of the eNOS
08/17/2010US7777013 A nucleoside coupled to a chain of 4-6 phosphate and linked distantly to nonhydrolysing groups and a label for greater stability and processibility when incorporated by polymerase into growing polynucleotide strands in a template dependent synthesis; biosynthesis; DNA sequencing; hybridization assays
08/17/2010US7776837 RNA aptamers and methods for identifying the same
08/17/2010US7776836 RNA aptamers and methods for identifying the same
08/17/2010US7776835 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting
08/17/2010US7776834 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides
08/17/2010US7776616 Hermatically sealed device comprising solid support for use in isolation of DNA from bodily fluids, wastes, excretions and blood
08/17/2010US7776598 Methods and compositions for polypeptide engineering
08/17/2010US7776595 Ex vivo gene therapy of HIV infection; CD34+ hematopoietic cells being transduced with a viral construct which expresses an anti-HIV agent
08/17/2010US7776593 Hes6 as a marker of pancreatic endocrine cells
08/17/2010US7776589 Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)
08/17/2010US7776587 Plasmids which express heterologous genes in both plant and animal cells; fusion proteins; gene therapy; high throughput assays; genomics; host cells; animal models
08/17/2010US7776577 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
08/17/2010US7776576 heat resistant non-maltogenic exoamylase comprising amino acid sequences having replacements, coded by nucleotide sequences; genetic engineering
08/17/2010US7776575 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence; glucose sensors, glucose assay kits
08/17/2010US7776572 Applying a coating solution comprising nonionic surfactant to the hydrophobic surface; drying the coated hydrophobic surface of to remove the solvent from the coating solution and thereby bind nonionic surfactant to the hydrophobic surface
08/17/2010US7776570 L-amino acid amide asymmetric hydrolase and DNA encoding the same
08/17/2010US7776568 Methods and kits using extended rhodamine dyes
08/17/2010US7776567 performing a nucleic acid amplification reaction by providing a reaction mixture comprising the target nucleic acid, reagents necessary for amplifying the target, and a fluorescent nucleic acid dye; used in DNA quantitation in real-time PCR
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776551 diagnosing non-syndromic mental retardation (NSMR) associated with psychomotor developmental delay
08/17/2010US7776536 Determining relative copy number of oncogenenucleotide sequences and precise mapping of chromosomal abnormalities associated with preferential cancers; diagnosing cell proliferative disorders
08/17/2010US7776534 Episomal fusion gene
08/17/2010US7776532 Method for in vitro recombination
08/17/2010US7776529 For fluorescent detection/quantitation of DNA; kits; staining solutions
08/17/2010US7776528 Radiative decay engineering
08/17/2010US7776526 conatacting an extracellular haemoglobin sample from annelids with dissociating agent e.g. a mixture containing dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) hydrochloride or beta-mercaptoethanol and a dissociation buffer for a sufficient length of time in order to separate the chains
08/17/2010US7776521 detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV); amplification
08/17/2010US7776518 Detection of survivin in the biological fluids of cancer patients
08/17/2010US7776344 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 899